Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
Shortened Duration of Dual Antiplatelet Therapy Following Percutaneous Coronary Intervention: A Contemporary Clinical Review
Dual antiplatelet therapy (DAPT) consisting of aspirin combined with a P2Y12 receptor inhibitor has been the standard of care for several decades in patients undergoing percutaneous coronary intervention (PCI) with implantation of coronary stents. According to current guidelines from the American College of Cardiology and American Heart Association (AC...
Source: Radcliffe Cardiology - Category: Cardiology Authors: dbarot525787 Source Type: research
More News: Angioplasty | Aspirin | Cardiology | Coronary Angioplasty | Heart | Percutaneous Coronary Intervention